📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma. (2017)

First Author: Fateen W

Attributed to: Nottingham Molecular Pathology Node (NMPN) for Integrated Multi-platform Biomarker Research and Knowledge Transfer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.2147/jhc.s144068

PubMed Identifier: 29082223

Publication URI: http://europepmc.org/abstract/MED/29082223

Type: Journal Article/Review

Volume: 4

Parent Publication: Journal of hepatocellular carcinoma

ISSN: 2253-5969